Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02411799 · ClinicalTrials.gov registry record

Instrumented Thoracic and Lumbar Arthrodesis Supplemented by the Implanet Jazz SystemTMd

A clinical trial, sponsored by Ohio State University.

Terminated
Registry status
154
Enrollment target

NCT02411799: Clinical Trial study, sponsored by Ohio State University.

NCT02411799 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02411799 was terminated before completion, sponsored by Ohio State University.

TERMINATED
Registry status
154 participants
Enrollment target

Study Summary

Establish a data repository of patients who have undergone thoracic and/or lumbar instrumented arthrodesis procedure supplemented by the Implanet Jazz System.

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2015-04
Est. Completion 2021-06-30
Ohio State University

552 total trials

Why NCT02411799 stopped before completion

NCT02411799 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02411799 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02411799 about?

NCT02411799 is a clinical study titled "Instrumented Thoracic and Lumbar Arthrodesis Supplemented by the Implanet Jazz SystemTMd". Establish a data repository of patients who have undergone thoracic and/or lumbar instrumented arthrodesis procedure supplemented by the Implanet Jazz System.

What is the current status of trial NCT02411799?

This trial is currently terminated. The enrollment target is 154 participants. The study started on 2015-04. Estimated completion is 2021-06-30.

Who is sponsoring clinical trial NCT02411799?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02411799, the US trial registry maintained by the National Library of Medicine. NCT02411799 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.